Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer응급실 스트레스 상태의 급성기에 대응하기 위해 항혈소판제 티클로피딘의 용도 변경: 코로나바이러스 감염 및 암 퇴치를 위한 기회Article Published on 2022-07-062022-09-11 Journal: Molecules [Category] COVID19(2023년), SARS, 신약개발, [키워드] Achille agent antiplatelet Antiplatelet agent approach approved drugs attribute Cancer Cancer cells Cell Coronavirus infections Coronavirus-2 COVID-19 demonstrated Endoplasmic reticulum endoplasmic reticulum (ER) ER membranes ER stress exacerbating Fighting heel homeostasis life cycle Metastasis Modification modulation opportunity P2Y12 P2Y12 inhibitors pathological conditions Perturbation phase promote receptor representing repurposing responsible SARS Coronavirus SARS-CoV-2 sigma sigma 1 receptor (S1R) terminal UPR the disease therapeutic intervention Therapies ticlopidine ticlopidine. Tumor tumor growth unfolded protein response UPR viral glycoprotein viral glycoproteins viral infection viral infections viral life cycle [DOI] 10.3390/molecules27144327 PMC 바로가기 [Article Type] Article
Impact of COVID-19 on cancer screening in South Korea Research Published on 2022-07-052022-10-05 Journal: Scientific Reports [Category] 치료기술, 치료법, [키워드] 95% CI 95% confidence interval Breast cancer Cancer Cancer screening cancer type chronic disease Chronic diseases CIs Colorectal cancer coronavirus disease COVID-19 cross-sectional declined defined eligible Impact incidence Intervention investigated Korean Mortality pandemic proportion random rate ratio reduce Screening significantly significantly lower South South Korea SRR survey [DOI] 10.1038/s41598-022-15778-3 [Article Type] Research
Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination간략한 연구 보고서: mRNA 기반 COVID-19 백신 접종을 통한 암 면역 요법에 대한 오래 지속되는 응답자의 항 SARS-CoV-2 면역Article Published on 2022-07-052022-09-12 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] analysed antibodies antibody Antibody Response antiviral immune response BNT162b2 Cancer Cancer immunotherapy Cohort Complete Control control group COVID COVID-19 COVID-19 vaccination develop ELISA generate group healthy control IFN-γ IgG titer IgGs immune Immune checkpoint inhibitor immune checkpoint inhibitors (ICIs) immune response Immunotherapy increase in independent induce Long long lasting responders long-lasting median mRNA-based COVID-19 vaccine mRNA-based vaccine mRNA-based vaccines NAb neutralizing antibody neutralizing capacity Patient patients treated prime-boost regimen receiving regimen respond Responder responders responses SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-specific IgG serum antibodies significantly increased solid tumors statistically significant T cell response T cell responses T cells the healthy the patient treated vaccination Vaccine virus [DOI] 10.3389/fimmu.2022.908108 PMC 바로가기 [Article Type] Article
Saquinavir: From HIV to COVID-19 and Cancer Treatment사퀴나비르: HIV에서 COVID-19 및 암 치료까지Review Published on 2022-07-052022-09-11 Journal: Biomolecules [Category] COVID19(2023년), SARS, 신약개발, 치료제, [키워드] 3CLpro anticancer antivirals Apoptosis approval approved drug Cancer Cancer cells cancer treatment Cell changed clinical trial clinical trials Combination COVID-19 COVID-19 outbreak cytotoxicity disease drug Drug repurposing Effect Follow-up help HIV impede in silico in vitro in vivo increased survival Invasion lack mind Neuroblastoma pathway pharmacological promise protease Protease inhibitor Research saquinavir saquinavir. SARS-CoV-2 main protease shown tested the SARS-CoV-2 therapy translated Treatment virus [DOI] 10.3390/biom12070944 PMC 바로가기 [Article Type] Review
Effect of treatment interruptions and outcomes in cancer patients undergoing radiotherapy during the first wave of COVID-19 pandemic in a tertiary care instituteObservational Study Published on 2022-07-042022-10-05 Journal: Journal of the Egyptian National Cancer Institute [Category] 임상, [키워드] Analysis Cancer cancer patient Care clinically cohorts of patients Comorbidities conducted COVID-19 COVID-19 pandemic COVID-19 patient disease Disease progression Effect effect of treatment eligible patient First wave Follow-up fraction Fractions general condition Immunosuppression impacted India less material Observational cohort study outcome outcomes Patient patients patients died patients treated positive Primary outcome Radiation radiation therapy Radiotherapy recovering from COVID-19 reported retrospective significant difference the patient Treatment Treatment interruption Treatment outcome treatment outcomes two groups [DOI] 10.1186/s43046-022-00129-0 PMC 바로가기 [Article Type] Observational Study
Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 LockdownSARS-CoV-2 폐쇄 후 입원한 암 환자의 영양 상태 및 염증에 미치는 영향Article Published on 2022-07-022022-09-11 Journal: Nutrients [Category] COVID19(2023년), SARS, 치료기술, [키워드] Admission age albumin albumin level albumin levels analyzed applied BMI bread Cancer cancer patient Cancer patients change cholesterol circulating Concentration Consumption CRP CRP level CRP levels decrease demonstrated dietary intake exhibited fruit Gender Impact improved nutritional status increase in Inflammation life lockdown Lymphocytes Malnutrition Mortality mortality data mortality rates must no statistical difference No statistical differences nutritional status obesity obesity paradox oncology oncology patients oncology patients. Patient Patients with cancer prealbumin Protein Quality of life reduction in mortality SARS-CoV-2 SARS-CoV-2 lockdown Screening significant difference Spanish status the SARS-CoV-2 Universal weight loss [DOI] 10.3390/nu14132754 PMC 바로가기 [Article Type] Article
JS1-1 Impact of COVID-19 for cancer screening and cancer treatment in JapanConference abstract Published on 2022-07-012022-10-05 Journal: Annals of oncology : official journal of the Europ [Category] 치료법, [키워드] Cancer cancer treatment COVID-19 Impact Japan [DOI] 10.1016/j.annonc.2022.05.381 [Article Type] Conference abstract
Recent advances on smart glycoconjugate vaccines in infections and cancerArticle Published on 2022-07-012022-11-15 Journal: The Febs Journal [Category] COVID19(2023년), SARS, 진단, [키워드] antigenic antigens approaches Biomedical research Cancer carbohydrate cellular cellular immune responses characterized death develop effective vaccine Efficacy effort epitope glycan glycosylation Human immunodeficiency virus humoral immune immune response immune system immunogenic immunoglobulin G response Immunological memory IMPROVE induce Infection Infectious disease joint morbidity outbreak pathogen pathogen-specific profile Protective provoke public health recent SARS-CoV-2 selective significantly T-cell immunity therapeutic vaccination Vaccine Vaccine development virus [DOI] 10.1111/febs.15909 PMC 바로가기
Coronaphobia: A barrier to ongoing cancer treatment?Article Published on 2022-07-012023-07-08 Journal: Psycho-oncology [Category] COVID19(2023년), [키워드] Anxiety Cancer COVID-19 Depression oncology pandemic Psycho-Oncology [DOI] 10.1002/pon.5907 PMC 바로가기
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study말초 림프구 하위 집합 수는 암 환자에서 SARS-CoV-2 mRNA-BNT162b2 백신 후 항체 반응을 예측합니다: Vax-On-Profile 연구 결과Article Published on 2022-07-012022-09-11 Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Adaptive immune response Analysis anti-RBD Antibody Response Antibody titer Antibody titers B cell B cells Cancer cancer patient Cancer patients Chemotherapy circulating collected correlation Corticosteroid corticosteroid therapy COVID-19 COVID-19 vaccination Cytotoxic chemotherapy defined Flow cytometry analysis helper cell humoral humoral immunogenicity Humoral response IgG IgG antibodies IgG antibody IgG titer immunosuppressive indicated interactions linear correlation lymphocyte Lymphocyte subset Lymphocyte subsets mRNA Multivariate analysis Negative predictive value Occurrence Patient peripheral Peripheral blood positive positive linear correlation predict Predictive Predictive value Protein Quantitative RBD receiving Receptor-binding domain Result ROC Curve SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 vaccine seroconversion rate seroconversion rates seroconversion response serologic testing Serologically shown significantly spike Spike protein subgroups subpopulations subset symptomatic infections T helper T helper cell T helper cell. tested the receptor-binding domain the SARS-CoV-2 treated Univariate analysis vaccination efficacy Vaccine [DOI] 10.1016/j.intimp.2022.108774 PMC 바로가기 [Article Type] Article